Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005 [Neurooncology]

Conclusion Long-term administration of mifepristone was well tolerated but had no impact on patients with unresectable meningioma.

http://jco.ascopubs.org/cgi/content/short/33/34/4093?rss=1

Source: Journal of Clinical Oncology - November 25, 2015 Category: Cancer & Oncology Authors: Ji, Rankin, Grunberg, Sherrod, Ahmadi, Townsend, Feun, Fredericks, Russell, Kabbinavar, Stelzer, Schott, Verschraegen Tags: Brain Tumors Neurooncology Source Type: research